In the latest episode of the weekly Pandemic Update podcast, ABA SVP Paul Benda discusses the glimmers of hope from last week that have turned into solid downward case count trends in some states. Benda also talks about some good news on long COVID-19, new government programs distributing test kits and masks, an OSHA update, early fourth dose data from Israel, and some potential future challenges.

ABA SVP Paul Benda provides an update about the current "unprecedented" case loads of COVID-19 in the 38th episode of the weekly ABA Pandemic Update podcast. Benda discusses glimmers of hope from Washington D.C., New York City and the United Kingdom, updates on hospitalizations and severity, timeline for vaccines for 2-to-4 year olds, fourth doses and a potential universal COVID-19 vaccine, and what the next month may look like.

ABA SVP Paul Benda provides an update about the Omicron variant of COVID-19 in the 37th episode of the weekly ABA Pandemic Update podcast. Benda discusses the incredible increase in cases, severity estimates, how vaccines are holding up and boosters for teenagers. Benda also talks about some bright spots for the immunocompromised, and where we go from here.

In the latest episode of the ABA Pandemic Update, Paul Benda focuses on the incredible growth of the omicron variant, what it's doing at home and abroad, how vaccines and other treatments such monoclonal antibodies are holding up, when to use a hard-to-get rapid antigen test, the status of vaccines for 2-5-year-olds and considerations for holiday travel and gatherings.

In the 35th episode of the weekly ABA Pandemic Update podcast, ABA SVP Paul Benda provides an update about the Omicron variant of COVID-19. He discusses current case counts, tracking the Omicron variant, how severe it is and if vaccines will continue to protect us. Benda also talks about early antibody neutralization studies that give an idea about how well vaccines will hold up and if the Pfizer vaccine or Moderna vaccine is better.

In the latest episode of the weekly ABA Pandemic Update podcast, ABA SVP Paul Benda provides an update about the Omicron variant of COVID-19, what is it, what does it mean, what can we do about it and how worried should we be. He also discusses booster shots and a potential timeline for Omicron variant specific booster shots.

In the latest episode of the weekly ABA Pandemic Update podcast, ABA SVP Paul Benda provides an update on continued rise in cases and about booster shot effectiveness, how long they last and how available they are. He also discusses how therapeutics may to the end of the pandemic and a new use case for mRNA vaccines.

In the latest episode of the weekly ABA Pandemic Update podcast, ABA SVP Paul Benda discusses bad news on rising case counts, new data on contagiousness of the Delta variant of COVID-19, vaccination protection timelines, vaccine booster shot and treatment news and an update on the Occupational Safety and Health Administration's emergency temporary standard.

In the latest episode of the weekly Pandemic Update podcast, ABA SVP Paul Benda discusses new data on recovered immunity, vaccines for children and a new study on Ivermectin. Benda also talks with ABA SVP Jonathan Thessin about the Occupational Safety and Health Administration's emergency temporary standard that will require all employers with 100 or more employees to be fully vaccinated or test weekly for COVID-19.

ABA SVP Paul Benda discusses the FDA review of children vaccines, booster shot data, predictions for the future and the factors that will affect it such as recovered immunity durability. He also talks about the new Delta plus variant and what to know about other "scariants."